Research Fellow: Computational Modelling in Immunology of Tuberculosis, University of Michigan, USA, deadline 19 March 2022
Weekly round-up #202
https://www.youtube.com/embed/DgchaulbtrY
World NTD Day and World Leprosy Day 2022 – Sunday, 30 January 2022
VALIDATE had a very busy day marking World Leprosy Day and World NTD Day on social media. We released our video "A few things you didn't know about Leishmaniasis" and created a number of shareable infographics about Leprosy. We encourage our members to use these resources for science engagement and get in touch if you have done any interesting outreach for your own research recently.
- GHIT Fund Investment Opportunities - invests in global partnerships for the discovery and development of new health technologies, including vaccines for infectious diseases prevalent in developing countries - ongoing scheme till 2023
- BBSRC follow-on funding and super follow-on fund - Apply for funding to support translating your research into practical applications. This may include a spin-out, a licensing opportunity or creating a social enterprise - Deadline 16 March 2022
- MRC Developmental Pathway Funding Scheme, 2022 - Apply for funding to develop and test novel therapeutics, medical devices, diagnostics and other interventions - deadline 23 March 2022
You can find a list of all relevant external funding we've spotted for our members on our external funding page.
Training Opportunities and Events:
Find more training and events opportunities on our Training and Events pages.
-
World Vaccine Congress 2022, Washington DC, USA, 18 - 22 April 2022
-
UK Cellular Microbiology Network: Exploring The Host-Pathogen Interface, University of Warwick, UK, 21-22 April 2022
-
European Melioidosis Congress 2022, Graz, Austria, 16 -18 May 2022
- Recent advances in T-cell receptor repertoire analysis: Bridging the gap with multimodal single-cell RNA sequencing, Valkiers S et al including VALIDATE member Nicky de Vrij, in Immuno Informatics
- Immunosuppressive features of the microenvironment in lymph nodes granulomas from tuberculosis and HIV co-infected patients, Ashenafi S et al The American Journal of Pathology
- BCG vaccination induces cross-protective immunity against pathogenic microorganisms, Soto J A et al in Trends in Immunology
- A virtual host model of Mycobacterium tuberculosis infection identifies early immune events as predictive of infection outcomes, Joslyn LR et al, in Journal of Theoretical Biology
Check out our Publications Page for members' publications and email VALIDATE@ndm.ox.ac.uk if you have a paper you would like us to include.
Highlights on Twitter this week:
We had a very busy World Leprosy and World NTD on Sunday 30 January. We tweeted a series of infographics about Leprosy using the #LeprosyFacts hashtag, reshared our video “A Vaccine for Leprosy?”, and shared our “A few things you might not know about leishmaniasis”. EVI took the opportunity of World NTD to share their work in support of a vaccine for leishmaniasis. Wellcome’s Director of Research Programmes Cheryl Moore talked about their £16 billion investment in research, STEM Village were seeking speakers for their LGBTQ+ seminar series, and we shared an educational video on leishmaniasis from Let’s Learn About Bugs. Hugh Kearns shared some useful planning guide resources. Write that PhD has some excellent advice for writing abstracts, research protocol, qualitative research, and structuring your thesis. Nature Careers had articles on industry and academia collaborations, the impact of the world’s deadliest diseases and the funding allocated to them, and advice for applying for grants. Stay up to date with all the relevant news and opportunities by following @NetworkVALIDATE on Twitter.
Published: 2 February 2022
